Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

OrderlyMeds vs Ravia Health

OrderlyMeds
Graded #78

Higher grade

vs+13.200000000000003
Ravia Health
Graded #347

Lower grade

The verdict

OrderlyMeds takes it — 72.4/100 to 59.2/100.

OrderlyMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. OrderlyMeds is a telehealth provider selling compounded semaglutide and tirzepatide with no membership fees or hidden costs.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOrderlyMeds +47
92
45
Dose & formulationOrderlyMeds +11
64
53
Clinical oversightRavia Health +5
82
87
Labs & monitoringRavia Health +12
53
65
FulfillmentOrderlyMeds +7
65
58
Contract termsOrderlyMeds +14
55
41
OrderlyMeds · left barRavia Health · right bar

The numbers

MetricOrderlyMedsRavia Health
WeighScore72.4/10059.2/100
GradeCC
Scorecard rank#78#347
Semaglutide$74/mo (starting dose, 2-mo starter plan, new patients only, compounded)Not disclosed
Tirzepatide$299/mo (compounded)Not disclosed
CoverageCoverage not published1 state
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
OrderlyMeds

Graded #78 · C

Strengths

  • The starter rate and the standing rate are both published, so the step-up is visible before signing up
  • No membership fees and no hidden costs, stated as such
  • The dose ladder is published: four weeks at 0.25 mg then four weeks at 0.5 mg
  • Brand-name routes are priced openly, at retail

Where it loses points

  • The $74 rate is a two-month starter plan billed as $149 up front, and it is open only to patients new to GLP-1 medication; the standing monthly rate is $149
  • Tirzepatide has no equivalent standing discount — $299/mo is the ongoing rate
  • Brand-name routes are priced at retail: Wegovy $1,839 and Zepbound $1,498
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Ravia Health

Graded #347 · C

Strengths

  • Integrative psychiatry model combines GLP-1 weight-loss with mental health and metabolic care under one board-certified NP provider
  • Founded by Dr. Raashida Portier (DNP, PMHNP-BC, FNP-BC); named clinician with dual board certifications in psychiatry and family medicine
  • Membership-supported ongoing care from $49/month provides medication management structure with consistent follow-up
  • Labs and metabolic workup available as part of integrative psychiatry model; lab testing noted in weight-loss program
  • Weight-loss page claims nationwide availability via Lyv Health partnership for eligible patients

Where it loses points

  • GLP-1 medication pricing fully gated — not disclosed until consultation; compounded vs. brand status unclear on public pages
  • Primarily a psychiatric practice — weight loss is a secondary service, not the core offering or brand identity
  • Core services explicitly Florida-only; nationwide weight-loss claim relies on Lyv Health partnership with unverified state coverage
  • No LegitScript certification or third-party accreditation found on public pages
  • Small single-provider practice with no published outcomes data or external reviews available

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard